3
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13093 |
Tauro-β-muricholic acid sodium
T-βMCA sodium |
FXR | Metabolism |
Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM). | |||
T37416 |
Tauro-α-muricholic Acid (sodium salt)
|
||
Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary bile acid α-muricholic acid . TαMCA is common in rodents but has also been found in small amounts in human serum. | |||
T63793 | Tauro-ω-muricholic acid sodium | ||
Tauro-ω-muricholic acid sodium (TωMCA sodium) 是一种tauro-α-muricholic acid 的类似物,是来源于肝脏的胆汁酸。Tauro-ω-muricholic acid sodium 能用作早发性新生儿败血症 (EOS) 和胆汁淤积的血清标志物。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T81030 |
Tauro-β-muricholic acid
TβMCA |
FXR | Metabolism |
Tauro-β-muricholic acid (TβMCA) 为一种具有三羟基结构的胆汁酸,是FXR的竞争性、可逆拮抗剂,IC50值为40 μM。此外,Tauro-β-muricholic acid 能够通过维持线粒体膜电位来阻抑胆汁酸引起的肝细胞凋亡,发挥抗凋亡功能。 |